Terms: = Pancreatic cancer AND ERBB3, c-erbB3, 2065, P21860, p180-ErbB3, c-erbB-3, ErbB-3, MDA-BF-1, HER3, p85-sErbB3, MGC88033, p45-sErbB3, ENSG00000065361, erbB3-S AND Prognosis
19 results:
1. Feasibility of Co-Targeting her3 and EpCAM Using Seribantumab and DARPin-Toxin Fusion in a pancreatic cancer Xenograft Model.
Xu T; Schulga A; Konovalova E; Rinne SS; Zhang H; Vorontsova O; Orlova A; Deyev SM; Tolmachev V; Vorobyeva A
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769161
[TBL] [Abstract] [Full Text] [Related]
2. In Vitro Tumor Cell-Binding Assay to Select High-Binding Antibody and Predict Therapy Response for Personalized
Hihara F; Matsumoto H; Yoshimoto M; Masuko T; Endo Y; Igarashi C; Tachibana T; Shinada M; Zhang MR; Kurosawa G; Sugyo A; Tsuji AB; Higashi T; Kurihara H; Ueno M; Yoshii Y
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628616
[TBL] [Abstract] [Full Text] [Related]
3. Identification of a DNA repair 9-gene signature for the overall survival prediction of pancreatic cancer.
Huang J; Mao Q; Sun X
Ann Diagn Pathol; 2022 Apr; 57():151883. PubMed ID: 35123152
[TBL] [Abstract] [Full Text] [Related]
4. Screening and Validation of Independent Predictors of Poor Survival in pancreatic cancer.
Liu S; Cai Y; Changyong E; Sheng J; Zhang X
Pathol Oncol Res; 2021; 27():1609868. PubMed ID: 34321959
[TBL] [Abstract] [Full Text] [Related]
5. A structural view of PA2G4 isoforms with opposing functions in cancer.
Stevenson BW; Gorman MA; Koach J; Cheung BB; Marshall GM; Parker MW; Holien JK
J Biol Chem; 2020 Nov; 295(47):16100-16112. PubMed ID: 32952126
[TBL] [Abstract] [Full Text] [Related]
6. The prognostic significance of human epidermal growth factor receptor family protein expression in operable pancreatic cancer : HER1-4 protein expression and prognosis in pancreatic cancer.
Li Q; Zhang L; Li X; Yan H; Yang L; Li Y; Li T; Wang J; Cao B
BMC Cancer; 2016 Nov; 16(1):910. PubMed ID: 27871278
[TBL] [Abstract] [Full Text] [Related]
7. Expression and Prognostic Significance of Human Epidermal Growth Factor Receptors 1, 2 and 3 in Periampullary Adenocarcinoma.
Elebro J; Heby M; Warfvinge CF; Nodin B; Eberhard J; Jirström K
PLoS One; 2016; 11(4):e0153533. PubMed ID: 27070783
[TBL] [Abstract] [Full Text] [Related]
8. Pyrosequencing-Based Assays for Rapid Detection of HER2 and her3 Mutations in Clinical Samples Uncover an E332E Mutation Affecting her3 in Retroperitoneal Leiomyosarcoma.
González-Alonso P; Chamizo C; Moreno V; Madoz-Gúrpide J; Carvajal N; Daoud L; Zazo S; Martín-Aparicio E; Cristóbal I; Rincón R; García-Foncillas J; Rojo F
Int J Mol Sci; 2015 Aug; 16(8):19447-57. PubMed ID: 26287187
[TBL] [Abstract] [Full Text] [Related]
9. HER family receptor expression and prognosis in pancreatic cancer.
Bittoni A; Mandolesi A; Andrikou K; Santoni M; Alfonsi S; Lanese A; Loretelli C; Pellei C; Piva F; Scarpelli M; Cascinu S
Int J Biol Markers; 2015 Jul; 30(3):e327-32. PubMed ID: 26109364
[TBL] [Abstract] [Full Text] [Related]
10. High expression of erbb3 binding protein 1 (EBP1) predicts poor prognosis of pancreatic ductal adenocarcinoma (PDAC).
Gong C; Zhang Y; Chen Y; Zhang H; Liu X; Xue H; Ji L; Wang L; Yang L; Zhou G; Wan C
Tumour Biol; 2015 Dec; 36(12):9189-99. PubMed ID: 26088450
[TBL] [Abstract] [Full Text] [Related]
11. Novel therapeutic targets for pancreatic cancer.
Tang SC; Chen YC
World J Gastroenterol; 2014 Aug; 20(31):10825-44. PubMed ID: 25152585
[TBL] [Abstract] [Full Text] [Related]
12. Investigational therapies targeting the ErbB (EGFR, HER2, her3, HER4) family in GI cancers.
Desai MD; Saroya BS; Lockhart AC
Expert Opin Investig Drugs; 2013 Mar; 22(3):341-56. PubMed ID: 23316969
[TBL] [Abstract] [Full Text] [Related]
13. Targeting EGFR in pancreatic cancer treatment.
Troiani T; Martinelli E; Capasso A; Morgillo F; Orditura M; De Vita F; Ciardiello F
Curr Drug Targets; 2012 Jun; 13(6):802-10. PubMed ID: 22458527
[TBL] [Abstract] [Full Text] [Related]
14. her3 overexpression as an independent indicator of poor prognosis for patients with curatively resected pancreatic cancer.
Hirakawa T; Nakata B; Amano R; Kimura K; Shimizu S; Ohira G; Yamada N; Ohira M; Hirakawa K
Oncology; 2011; 81(3-4):192-8. PubMed ID: 22067729
[TBL] [Abstract] [Full Text] [Related]
15. Amphiregulin regulates the activation of ERK and Akt through epidermal growth factor receptor and her3 signals involved in the progression of pancreatic cancer.
Yotsumoto F; Fukami T; Yagi H; Funakoshi A; Yoshizato T; Kuroki M; Miyamoto S
Cancer Sci; 2010 Nov; 101(11):2351-60. PubMed ID: 20726858
[TBL] [Abstract] [Full Text] [Related]
16. HER-family gene amplification and expression in resected pancreatic cancer.
te Velde EA; Franke AC; van Hillegersberg R; Elshof SM; de Weger RW; Borel Rinkes IH; van Diest PJ
Eur J Surg Oncol; 2009 Oct; 35(10):1098-104. PubMed ID: 19304440
[TBL] [Abstract] [Full Text] [Related]
17. Epidermal growth factor receptor tyrosine phosphorylation and signaling controlled by a nuclear receptor coactivator, amplified in breast cancer 1.
Lahusen T; Fereshteh M; Oh A; Wellstein A; Riegel AT
Cancer Res; 2007 Aug; 67(15):7256-65. PubMed ID: 17671194
[TBL] [Abstract] [Full Text] [Related]
18. Growth factor receptors are differentially expressed in cancers of the papilla of vater and pancreas.
Friess H; Wang L; Zhu Z; Gerber R; Schröder M; Fukuda A; Zimmermann A; Korc M; Büchler MW
Ann Surg; 1999 Dec; 230(6):767-74; discussion 774-5. PubMed ID: 10615931
[TBL] [Abstract] [Full Text] [Related]
19. Molecular genetics of malignant insulinoma.
Pavelic K; Hrascan R; Kapitanovic S; Vranes Z; Cabrijan T; Spaventi S; Korsic M; Krizanac S; Li YQ; Stambrook P; Gluckman JL; Pavelic ZP
Anticancer Res; 1996; 16(4A):1707-17. PubMed ID: 8712689
[TBL] [Abstract] [Full Text] [Related]
